Pediatric Preclinical Testing Consortium

The NCI PPTC addresses key challenges associated with the development of new therapies for children with cancer by developing reliable preclinical testing data for pediatric drug candidates that can be used to inform new agent prioritization decisions.

Funded by the National Cancer Institute, the PPTC consists of a Coordinating Center as well as five Research Programs that perform in vivo testing of pediatric anticancer drug candidates: